z-logo
open-access-imgOpen Access
C-Terminal Plays as the Possible Nucleation of the Self-Aggregation of the S-Shape Aβ11–42 Tetramer in Solution: Intensive MD Study
Author(s) -
Nguyễn Thanh Tùng,
Philippe Derreumaux,
Van V. Vu,
Pham Cam Nam,
Sơn Tùng Ngô
Publication year - 2019
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.9b00992
Subject(s) - tetramer , terminal (telecommunication) , nucleation , chemistry , crystallography , physics , thermodynamics , computer science , biochemistry , enzyme , telecommunications
Amyloid beta (Aβ) peptides are characterized as the major factors associated with neuron death in Alzheimer's disease, which is listed as the most common form of neurodegeneration. Disordered Aβ peptides are released from proteolysis of the amyloid precursor protein. The Aβ self-assembly process roughly takes place via five steps: disordered forms → oligomers → photofibrils → mature fibrils → plaques. Although Aβ fibrils are often observed in patient brains, oligomers were recently indicated to be major neurotoxic elements. In this work, the neurotoxic compound S-shape Aβ 11-42 tetramer (S4Aβ 11-42 ) was investigated over 10 μs of unbiased MD simulations. In particular, the S4Aβ 11-42 oligomer adopted a high dynamics structure, resulting in unsuccessful determination of their structures in experiments. The C-terminal was suggested as the possible nucleation of the Aβ 42 aggregation. The sequences 27-35 and 39-40 formed rich β-content, whereas other residues mostly adopted coil structures. The mean value of the β-content over the equilibrium interval is ∼42 ± 3%. Furthermore, the dissociation free energy of the S4Aβ 11-42 peptide was predicted using a biased sampling method. The obtained free energy is Δ G US = -58.44 kcal/mol which is roughly the same level as the corresponding value of the U-shape Aβ 17-42 peptide. We anticipate that the obtained S4Aβ 11-42 structures could be used as targets for AD inhibitor screening over the in silico study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom